PCSK9: A link between air pollution and cardiovascular disease?

被引：0
|
作者：
Prochaska, Juergen H. [1 ,2 ,3 ]
Troebs, Sven-Oliver [3 ,4 ]
Wild, Philipp S. [1 ,2 ,3 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Prevent Cardiol & Prevent Med, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany
[3] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Berlin, Germany
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Cardiol 1, Mainz, Germany
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2020年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：576 / 577
页数：2
相关论文
共 50 条
  • [41] PCSK9 in diabetic kidney disease
    Elewa, Usama
    Fernandez-Fernandez, Beatriz
    Mahillo-Fernandez, Ignacio
    Martin-Cleary, Catalina
    Belen Sanz, Ana
    Sanchez-Nino, Maria D.
    Ortiz, Alberto
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (09) : 779 - 786
  • [42] PCSK9 in chronic kidney disease
    P. Pavlakou
    E. Liberopoulos
    E. Dounousi
    M. Elisaf
    [J]. International Urology and Nephrology, 2017, 49 : 1015 - 1024
  • [43] PCSK9 IN DIABETIC KIDNEY DISEASE
    Elewa, Usama
    Fernandez-Fernandez, Beatriz
    Mahillo-Fernandez, Ignacio
    Sanchez-Nino, Maria D.
    Ortiz, Alberto
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 211 - 212
  • [44] PCSK9 in chronic kidney disease
    Pavlakou, P.
    Liberopoulos, E.
    Dounousi, E.
    Elisaf, M.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (06) : 1015 - 1024
  • [45] NO ASSOCIATION BETWEEN CHANGES IN LIPID PARAMETERS AND TOTAL PCSK9 IN CORONARY ARTERY DISEASE PATIENTS TREATED WITH PCSK9 INHIBITORS
    Ugovsek, S.
    Likozar, A. Rehberger
    Sebestjen, M.
    [J]. ATHEROSCLEROSIS, 2023, 379 : S173 - S173
  • [46] PCSK9
    Abifadel, M.
    Boileau, C.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [47] Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
    Pecin, Ivan
    Hartgers, Merel L.
    Hovingh, G. Kees
    Dent, Ricardo
    Reiner, Zeljko
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (13) : 1383 - 1401
  • [48] Need of education and training of healthcare professionals on the PCSK9 inhibitors in cardiovascular disease
    Schjott, Jan
    Heitmann, Kristine
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2024,
  • [49] VXX-401, AN INVESTIGATIONAL PCSK9 VACCINE FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Dodart, Jean-Cosme
    Boyd, Justin
    Chirinos-Rojas, Carlos
    Lu, Hanxin
    Wang, Shixia
    Ding, Shuang
    Thibodeaux, Brett
    Vroom, Madeline
    Sahni, Jaya
    Ramos, Martina M.
    Liu, Zhi
    Wang, Lixia
    Mohapatra, Nrusingh
    Longo, Matthew
    Wiggins, Jonathan
    Sun, Yushuang
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1636 - 1636
  • [50] Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease
    Dave L. Dixon
    Lauren G. Pamulapati
    John D. Bucheit
    Evan M. Sisson
    Shawn R. Smith
    Caroline J. Kim
    George F. Wohlford
    Jonah Pozen
    [J]. Current Atherosclerosis Reports, 2019, 21
12345